Medical termination of pregnancy at 63 to 83 days gestation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 6, 1999, Pages 535-539

  Gouk, Elaine V ^a   Lincoln, Karen ^a   Khair, Anu ^a   Haslock, Joanne ^a   Knight, June ^a   Cruickshank, Derek J ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; GENERAL HOSPITAL; GESTATIONAL AGE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033061419     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08320.x     Document Type: Article

References (20)

1. UK Multicentre Study: Final Results. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation. Contraception 1997; 55: 1–5.
2. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993; 8: 1502–1505.
3. World Health Organization Task Force On Post-Ovulatory Methods Of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307: 532–537.
4. Baird DT, Sukcharoen N, Thong KJ. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 1995; 10: 1521–1527.
5. Jannet D, Aflak N, Abankwa A, Carbonne B, Marpeau L, Milliez J. Termination of second and third trimester pregnancies with mifepristone and misoprostol. Eur J Obstet Gynecol Reprod Biol 1996; 70: 159–163.
6. El-Refaey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). Hum Reprod 1993; 8: 1744–1746.
7. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983–987.
8. Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in the termination of second-trimester pregnancy. Obstet Gynecol 1997; 90: 735–738.
9. Abortion Statistics 1995(England and Wales) (Series AB No22). Office for National Statistics. London : HMSO, 1997.
10. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford Blackwell Science, 1994.
11. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241–1247.
12. Peyron R, Aubeny E, Targosz V et al. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509–1513.
13. Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9–13 weeks’ amenorrhoea with mifepristone and misoprostol. Lancet 1998; 352: 542–543.
14. Cameron ST, Glasier AF, Logan J, Benton L, Baird DT. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Inhary of Edinburgh. Br J Obstet Gynuecol 1996; 103: 1222–1229.
15. Howie FL, Henshaw RC, Naji SA, Russel IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997; 104: 829–833.
16. Chan YF, Po PC, Ma HK. Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost. Contraception 1993; 47: 85–95.
17. Rodger MW, Baird DT. Blood loss following induction of early abortion using mifepristone (RU486) and a prostaglandin analogue (gemeprost). Contraception 1989; 40: 439–447.
18. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: Efficacy and early medical sequelae. Hum Reprod 1994; 9: 2167–2172.
19. Sawaya G, Grady D, Kerlikowske K, Grimes D. Antibiotics at the time of induced abortion: The case for universal prophylaxis based on a meta analysis. Obsret Gynecol 1996; 87: 884–890.
20. Royal College of Obstetricians and Gynaecologists. Induced Abortion. Clinical ‘Greentop’ Guidelines: No. 11, July 1997.